Is Calliditas Therapeutics AB (publ) (CALT) a Buy, Sell, or Hold?
NASDAQ : CALT
Calliditas Therapeutics AB (publ) — Institutional Ownership
$40.0001 USD
-$0.04 (-0.1%)
- Volume
- 9.8K
- Average Volume
- 7.59K
- Market Capitalization
- $2.15B
- P/E Ratio
- -21.92
- Dividend Yield
- 0.00%
- Price Target
- $39.50
- Year High
- $43.00
- Year Low
- $15.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.13
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2024-09-23 | ASAHI KASEI CORPORATION | 53.16M | 98.38% |
| 2024-06-04 | ASAHI KASEI CORPORATION | 29.33M | 54.60% |
| 2023-01-26 | Swedbank Robur Fonder AB | - | 0.00% |
| 2022-03-02 | Linc AB | 5.49M | 10.50% |
| 2022-03-02 | Bengt Julander | 5.49M | 10.50% |
| 2022-02-14 | Fjärde AP-fonden (Fourth Swedish National Pension Fund) | 2.68M | 5.10% |
| 2022-02-14 | Swedbank Robur Fonder AB | 2.64M | 5.04% |
| 2020-06-08 | BVF Inc. | 4.78M | 9.70% |
| 2020-06-08 | Mark N. Lampert | 4.78M | 9.70% |
| 2020-06-08 | Biotechnology Value Fund, L.P. | 2.46M | 5.00% |
| 2020-06-08 | BVF I GP LLC | 2.46M | 5.00% |
| 2020-06-08 | Biotechnology Value Fund II, L.P. | 1.88M | 3.80% |
| 2020-06-08 | BVF II GP LLC | 1.88M | 3.80% |
| 2020-06-08 | Biotechnology Value Trading Fund OS LP | 327.36K | 1.00% |
| 2020-06-08 | BVF Partners OS Ltd. | 327.36K | 1.00% |
| 2020-06-08 | BVF GP HOLDINGS LLC | 4.35M | 8.80% |
| 2020-06-08 | BVF Partners L.P. | 4.78M | 9.70% |
CALT Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $259.22 | 26.84M | $6.96B | $973.73M | $979.13M | $6.96B |
| 2022-12-31 | $176.91 | 26.51M | $4.69B | $1.25B | $728.82M | $4.17B |
| 2021-12-31 | $223.79 | 25.41M | $5.69B | $955.51M | $213.22M | $4.95B |
| 2020-12-31 | $276.29 | 22.44M | $6.2B | $996.3M | $4.79M | $5.21B |
| 2019-12-31 | $183.61 | 18.47M | $3.39B | $753.54M | $6.07M | $2.64B |
| 2018-12-31 | $173.94 | 12.97M | $2.26B | $646.18M | -$ | $1.61B |
| 2017-12-31 | $160.09 | 16.95M | $2.71B | $57.35M | $470K | $2.66B |
| 2016-12-31 | $178.13 | 16.62M | $2.96B | $24.24M | $30M | $2.97B |
| 2015-12-31 | $165.60 | 16.62M | $2.75B | $25.16M | -$ | $2.73B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-06-30 | $409.64 | 26.84M | $11B | $797.28M | $1.01B | $11.21B |
| 2024-03-31 | $226.39 | 26.84M | $6.08B | $810.32M | $1.02B | $6.28B |
| 2023-12-31 | $259.22 | 26.84M | $6.96B | $973.73M | $979.13M | $6.96B |
| 2023-09-30 | $199.38 | 26.84M | $5.35B | $786.88M | $770.16M | $5.33B |
| 2023-06-30 | $170.78 | 26.84M | $4.58B | $866.18M | $779.56M | $4.5B |
| 2023-03-31 | $248.67 | 26.84M | $6.67B | $1.01B | $746.9M | $6.41B |
| 2022-12-31 | $176.91 | 26.63M | $4.71B | $1.25B | $728.82M | $4.19B |
| 2022-09-30 | $168.21 | 26.62M | $4.48B | $736.16M | $467.32M | $4.21B |
| 2022-06-30 | $181.34 | 26.6M | $4.82B | $846.8M | $458.03M | $4.43B |
| 2022-03-31 | $179.69 | 26.19M | $4.71B | $825.41M | $214.49M | $4.1B |
| 2021-12-31 | $223.79 | 26.17M | $5.86B | $955.51M | $213.22M | $5.11B |
| 2021-09-30 | $189.25 | 25.53M | $4.83B | $1.16B | $187.43M | $3.86B |